Alpha-Chain cross-linking in fibrin(ogen) Marburg

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Fibrinogen stabilization is crucial for clot integrity, involving factor XIIIa-mediated cross-linking.
• The A alpha chain of fibrinogen plays a key role in this cross-linking process.
• Fibrinogen Marburg possesses truncated A alpha chains, affecting its cross-linking domain.

Purpose of the Study:

• To investigate the impact of A alpha chain truncation in fibrinogen Marburg on fibrin stabilization.
• To characterize the factor XIIIa-mediated cross-linking of Marburg fibrin alpha chains.
• To assess the interaction of Marburg fibrin with alpha 2 antiplasmin (alpha 2PI).

Main Methods:

• Immunochemical studies using immunoblotting.
• In vitro plasma clotting system with Marburg and control plasmas.
• Evaluation of alpha chain cross-linking using a synthetic alpha 2PI peptide and native cross-linked species.

Main Results:

• Marburg alpha chains incorporated synthetic peptide, forming smaller monomers compared to controls.
• Marburg fibrin alpha chains formed oligomers, polymers, and alpha 2PI heterodimers, but these were smaller.
• Deletion of A alpha 461-610 region prevented extensive alpha polymer network formation.

Conclusions:

• Fibrinogen Marburg's truncated A alpha chains hinder extensive alpha polymer formation.
• Initial fibrin stabilization events, including factor XIIIa binding and limited cross-linking, are preserved.
• The study elucidates the role of the A alpha chain C-terminus in fibrin clot structure.